Research in Alzheimer Disease and Dementia: Jessica Zwerling, MD, MS
July 25th 2021The director of Montefiore Hudson Valley Center of Excellence for Alzheimer’s Disease, associate professor of neurology, Albert Einstein College of Medicine, discussed recent developments in Alzheimer disease research, including FDA approval of aducanumab, as well as the importance of engaging community-based organizations to improve patient care.
Biogen Head Pens Open Letter Regarding Aducanumab Controversy in Alzheimer
July 23rd 2021Alfred Sandrock, MD, PhD, head of research and development, Biogen, has published an open letter to the Alzheimer community in an attempt to clarify “misinformation and misunderstanding” that has moved “outside the boundaries of legitimate scientific deliberation.”
Changes to Sleep Care Throughout the COVID-19 Pandemic: Michael Thorpy, MD
July 22nd 2021The director of the Sleep-Wake Disorders Center at Montefiore Medical Center discussed the adjustments clinicians and patients with sleep disorders made throughout the pandemic, including the increased use of telemedicine.
Telehealth and Trial Recruitment in Alzheimer Disease: Jessica Zwerling, MD, MS
July 22nd 2021In Alzheimer disease and dementia, Jessica Zwerling, MD, MS, director, Montefiore Hudson Valley Center of Excellence for Alzheimer’s Disease, believes normalizing trial recruitment aids and telehealth to increase participation is another way to ease delivery of care.
Floodlight App Captures MS Functional Impairment, Proof-of-Concept Supports Clinical Use
July 21st 2021The majority of tests with the tool correlated with Expanded Disability Status Scale scores, 29-item Multiple Sclerosis Impact Scale items or subscales scores, and/or normalized brain volume measures.
Pipeline Update: Status of Clinical Development for Multiple Sclerosis
July 20th 2021The development of agents for MS to address the treatment needs of patients with progressive and relapsing disease has been an ongoing effort that has brought forth a few new potential disease-modifying therapies.
Identifying Atypical Forms, Presentations of Demyelinating Disease: Oliver Tobin, MBBCh, BAO, PhD
July 20th 2021The associate professor of neurology at Mayo Clinic Rochester discusses the importance of alternative diagnoses and rarer presentations of MS, in order to avoid misdiagnoses and inappropriate treatment for patients.